Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. - Wikidata - awgldk - TriplyDB

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.

http://www.wikidata.org/entity/Q42286897

about

Rifabutin for treating pulmonary tuberculosis Rifabutin for treating pulmonary tuberculosis Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis Evaluation of rifapentine in long-term treatment regimens for tuberculosis in mice Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model.Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice Evaluation of once-weekly therapy for tuberculosis using isoniazid plus rifamycins in the mouse aerosol infection model Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages Anticytomegaloviral activity of methotrexate associated with preferential accumulation of drug by cytomegalovirus-infected cells How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis Tuberculosis and HIV: a partnership against the most vulnerable.Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens.Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.Rifapentine: its role in the treatment of tuberculosis.Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice.Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in mice.Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations.The use of anti-tuberculosis therapy for latent TB infection An update on the use of rifapentine for tuberculosis therapy.Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model.Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice.Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis New regimens to prevent tuberculosis in adults with HIV infection Role of pharmacogenomics in the treatment of tuberculosis: a review Bactericidal and sterilizing activities of several orally administered combined regimens against Mycobacterium ulcerans in mice A physiologically based pharmacokinetic model of rifampin in mice.Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis Leprosy therapy, past and present: can we hope to eliminate it?Current management options for latent tuberculosis: a review.The challenges of pharmacokinetic variability of first-line anti-TB drugs.Assessment of the Efficacy of New Anti-Tuberculosis Drugs.Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin.Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis.Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice.

P2860

Q24242892-F6760E6B-589F-4BF5-898F-B668D9649A76 Q24245293-0C91703D-E9D8-4A61-8FF2-CA67BFA58831 Q24650581-EB3DE052-6C4A-40BD-B7F4-3B26B18D31C5 Q28343546-AB5628E3-A2F9-42B0-9BAA-471835C0C9CA Q28343604-233F590F-DD09-47C5-94BD-254390467B37 Q28344872-C1472BFB-1EAC-470C-A2E0-6F75EE2D5982 Q28364123-21B5DD5F-9007-4725-A118-DE843AC22F84 Q28368450-D182DE1A-BD10-45D5-8F04-B79BEC3BBD44 Q28369131-3319AB2C-9CDE-4B1B-9A53-19B6D042679B Q28369170-9CD4B3CB-E941-4263-8726-062ACA05F995 Q28378747-47DA5193-092C-4132-99E0-25F23B582994 Q28379178-9CAC4533-D77B-47B6-9215-483BF6B3195A Q28379180-4075BAF9-31F0-48CD-BBA1-41A1765E7282 Q28379615-E0FF580E-E7DC-4E85-B561-CFC0C43291AA Q30336184-E08CAAD2-E8E8-4081-87D8-086A4EB3EAC3 Q31369223-7E9F6054-C116-4124-9BFE-390E7F0D22CF Q33735589-5FDC2096-D6FF-4C5C-B1CF-B4F0FEA0046B Q33779876-63F8A728-2909-4972-881C-D4B1A7C9B664 Q33976250-6CA80138-AD0E-48C8-8267-54E8E0DBD2A0 Q33980894-A82C105F-AB24-48F6-A71C-D470B09E3B79 Q34077125-ED6F9337-527A-41A9-8772-5625A39FC91D Q34150929-AA74B03C-8AB3-499D-80A8-07DB0887B79E Q35026573-BF02009C-B143-4655-81A0-F27EA9EA4672 Q35084363-124594B3-5FF7-4866-80AC-2CFF7F0F992C Q35112158-CCA628C6-F694-47CD-8ADB-F02A86A14283 Q35122437-3D5F6FB3-5E0A-47EC-804F-2561E45B0E17 Q35776635-8A646E5B-0262-4469-BB3F-8A7C579FE1E7 Q36012300-DA753149-FB2D-4C6E-8A4B-05BA67959413 Q36125227-98FC3146-9A28-4C24-B953-888C7B48F4A7 Q36441540-FCAFDEFA-58BB-414C-9825-1B4CECC041C0 Q36703065-6C858291-5DF6-4B55-ADF4-72319B444545 Q36757635-20F0598F-21A3-49AA-85A2-FAF1FA024858 Q37282694-30720226-298C-46C9-B06B-8BD3D8F21A3D Q37856731-58B8A033-C14C-4E78-B2C9-8B2E51C9AE19 Q38066198-0B939DC2-AA72-4314-9923-97FDA15D4D43 Q38977166-D434ED93-C70F-45B9-A9FA-6CF86914B1D4 Q41572870-B249C250-A0E8-40E6-87F9-77EDBCD4DF12 Q42861000-8174ABEA-C645-4C1A-BB8A-0C4DE75D1E85 Q52559111-48305FC4-1161-4F6F-B886-8F657819659F Q54137044-CB006407-6493-4C45-A2A6-B22DECA8B171

P2860

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.

http://www.wikidata.org/entity/Q42286897

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

1993年论文

@zh

1993年论文

@zh-cn

name

Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.

@en

Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.

@nl

type

label

Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.

@en

Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.

@nl

prefLabel

Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.

@en

Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.

@nl

P1433

Q42286897-405962A2-ABAC-4BC9-B5BC-ED93343B5054

P1476

Q42286897-F65A452E-D515-48BA-A360-4DA420E0B28F

P2093

Q42286897-0B49E3AD-1550-4381-A57A-00A2DFF7262A

Q42286897-135352B4-324F-4FCB-8451-33DDDD728418

Q42286897-220EF750-7937-4E30-81BE-679ADA94A411

Q42286897-4995735E-23AE-46CB-AE74-35D0093EF27A

Q42286897-94AD7A13-E3AA-4E95-B0C7-0677AE1AD10C

Q42286897-BC478349-BFF2-445C-BD15-6BD9D76B76EB

Q42286897-D7B14DDB-4A46-4941-A647-9CBDBD6147BB

Q42286897-F5B1E106-2B3D-47D3-9896-B588DA686922

P2860

Q42286897-0130A78A-CD15-4F13-990A-8F3FA1F9118C

Q42286897-07055912-0E4B-4EA5-A113-D95AEF82B375

Q42286897-0A9F3A98-367F-48E5-BF55-A4E323FAB626

Q42286897-0AF0B64F-45AE-42F0-AED8-4AD9BC1F5E34

Q42286897-0B173BE4-1B4B-4BBA-B9EF-2504397435F3

Q42286897-1F12B1DE-F9DB-4442-8956-383BB3FBD158

Q42286897-780856A9-A1E2-4A08-8F38-7B58B9F1351C

Q42286897-86720809-F7F7-4910-BD50-F512736CCEB1

Q42286897-931B1AF9-A366-47E6-8548-5076B558C03D

Q42286897-93A680E8-4498-4068-B78D-0FBD3B01208C

P304

Q42286897-6E8E634B-53A6-40BC-B58C-B58BEC88B111

P31

Q42286897-A6CE11A3-B431-4486-8B1B-DC9F94BF652C

P356

Q42286897-0782A273-66CB-4450-8BCB-47C341097B8E

P433

Q42286897-A6811BCF-4554-46AC-8DBF-82DEB9AA77E2

P478

Q42286897-F8B3C214-2A1A-4FCA-B65A-FF352C7A2251

P577

Q42286897-FF8A1DA8-CAB0-4D23-959B-876C6E1EB8FD

P698

Q42286897-3B7F4B71-0395-4175-93FC-3DCFC7B36058

P921

Q42286897-4B0339CE-D1B8-4CD9-9374-BDEE9A4D999A

P356

148.6_PT_1.1541

P1433

The American Review of Respiratory Disease

P1476

Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.

@en

P2093

Grosset J

http://www.w3.org/2001/XMLSchema#string

Ji B

http://www.w3.org/2001/XMLSchema#string

Lacroix C

http://www.w3.org/2001/XMLSchema#string

O'Brien RJ

http://www.w3.org/2001/XMLSchema#string

Olliaro P

http://www.w3.org/2001/XMLSchema#string

Raviglione MC

http://www.w3.org/2001/XMLSchema#string

Roscigno G

http://www.w3.org/2001/XMLSchema#string

Truffot-Pernot C

http://www.w3.org/2001/XMLSchema#string

P2860

Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis

Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages

HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention.

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.

Pharmacokinetics of rifabutin.

Intraphagocytic penetration of antibiotics.

Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis.

In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.

In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis.

Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy.

P304

1541-1546

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/AJRCCM/148.6_PT_1.1541

http://www.w3.org/2001/XMLSchema#string

P433

6 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P577

1993-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8256897

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde